TY  - JOUR 
AU  - Hernández-Sánchez, María
AU  - Rodríguez Vicente, Ana E.
AU  - Kohlmann, Alexander
AU  - Benito Sánchez, Rocío
AU  - García, Juan Luis
AU  - Risueño, Alberto
AU  - Fermiñán, Encarna
AU  - Rivas Sanz, Javier de las
AU  - González, Marcos
AU  - Hernández Rivas, Jesús María
PY  - 2014
SN  - 2314-6133
UR  - http://hdl.handle.net/10366/140697
AB  - [EN] TET2 is involved in a variety of hematopoietic malignancies, mainly in myeloid malignancies. Most mutations of TET2 have been identified in myeloid disorders, but some have also recently been described in mature lymphoid neoplasms. In contrast to...
LA  - eng
KW  - TET2
KW  - Chronic Lymphocytic Leukemia
KW  - Leukemia, Lymphoid
TI  - TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
DO  - 10.1155/2014/814294
T2  - BioMed Research International
VL  - 2014
M2  - 1
ER  -